163 related articles for article (PubMed ID: 17475963)
41. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer.
Eschwege F; Sancho-Garnier H; Gerard JP; Madelain M; DeSaulty A; Jortay A; Cachin Y
NCI Monogr; 1988; (6):275-8. PubMed ID: 2451135
[TBL] [Abstract][Full Text] [Related]
42. Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
Kang CJ; Lin CY; Yang LY; Ho TY; Lee LY; Fan KH; Wang HM; Huang SF; Chang KP; Fang KH; Ng SH; Liao CT; Yen TC
J Nucl Med; 2015 Jan; 56(1):22-30. PubMed ID: 25525186
[TBL] [Abstract][Full Text] [Related]
43. FDG-PET prediction of head and neck squamous cell cancer outcomes.
Schwartz DL; Rajendran J; Yueh B; Coltrera MD; Leblanc M; Eary J; Krohn K
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1361-7. PubMed ID: 15611393
[TBL] [Abstract][Full Text] [Related]
44. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.
Allal AS; Dulguerov P; Allaoua M; Haenggeli CA; El-Ghazi el A; Lehmann W; Slosman DO
J Clin Oncol; 2002 Mar; 20(5):1398-404. PubMed ID: 11870185
[TBL] [Abstract][Full Text] [Related]
45. Carcinoma of the oropharynx: factors affecting outcome.
Sundaram K; Schwartz J; Har-El G; Lucente F
Laryngoscope; 2005 Sep; 115(9):1536-42. PubMed ID: 16148691
[TBL] [Abstract][Full Text] [Related]
46. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Roh JL; Ryu CH; Choi SH; Kim JS; Lee JH; Cho KJ; Nam SY; Kim SY
J Nucl Med; 2007 Feb; 48(2):240-6. PubMed ID: 17268021
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
Speleman L; Kerrebijn JD; Look MP; Meeuwis CA; Foekens JA; Berns EM
Head Neck; 2007 Apr; 29(4):341-50. PubMed ID: 17163465
[TBL] [Abstract][Full Text] [Related]
48. Treatment results of radiotherapy with or without surgery for posterior pharyngeal wall cancer of oropharynx and hypopharynx: prognostic value of tumor extension.
Yoshida K; Inoue T; Inoue T; Tanaka E; Shiomi H; Teshima T
Radiat Med; 2004; 22(1):30-6. PubMed ID: 15053173
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Naitou K; Ueda Y; Ouchi Y
AJR Am J Roentgenol; 2009 Apr; 192(4):W156-60. PubMed ID: 19304675
[TBL] [Abstract][Full Text] [Related]
50. Basaloid squamous cell carcinoma of the oropharynx: an analysis of 650 cases.
Fritsch VA; Lentsch EJ
Otolaryngol Head Neck Surg; 2013 Apr; 148(4):611-8. PubMed ID: 23386625
[TBL] [Abstract][Full Text] [Related]
51. Treatment of penile carcinoma: to cut or not to cut?
Ozsahin M; Jichlinski P; Weber DC; Azria D; Zimmermann M; Guillou L; Bulling S; Moeckli R; Mirimanoff RO; Zouhair A
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):674-9. PubMed ID: 16949770
[TBL] [Abstract][Full Text] [Related]
52. Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.
Ho KC; Wang CC; Qiu JT; Lai CH; Hong JH; Huang YT; Huang KG; Chao A; Lin G; Yen TC
Gynecol Oncol; 2011 Nov; 123(2):253-6. PubMed ID: 21807401
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for hemorrhage after chemoradiation for oropharyngeal squamous cell carcinoma.
Self EM; Bumpous J; Ziegler C; Wilson L; Potts K
JAMA Otolaryngol Head Neck Surg; 2013 Apr; 139(4):356-61. PubMed ID: 23599070
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy.
Shimizu M; Mitsudo K; Koike I; Taguri M; Iwai T; Koizumi T; Oguri S; Kioi M; Hirota M; Inoue T; Tohnai I
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):239-47. PubMed ID: 26768076
[TBL] [Abstract][Full Text] [Related]
55. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Krabbe CA; Pruim J; Dijkstra PU; Balink H; van der Laan BF; de Visscher JG; Roodenburg JL
J Nucl Med; 2009 Dec; 50(12):1940-7. PubMed ID: 19910434
[TBL] [Abstract][Full Text] [Related]
56. [Clinical and histopathological results after local chemoembolization of oral and oropharyngeal carcinoma--comparison with intraarterial chemoperfusion].
Rohde S; Turowski B; Berkefeld J; Kovács AF
Rofo; 2006 Oct; 178(10):979-86. PubMed ID: 17021977
[TBL] [Abstract][Full Text] [Related]
57. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.
Ng SH; Chan SC; Liao CT; Chang JT; Ko SF; Wang HM; Chin SC; Lin CY; Huang SF; Yen TC
Neuroradiology; 2008 Nov; 50(11):969-79. PubMed ID: 18600319
[TBL] [Abstract][Full Text] [Related]
58. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
[TBL] [Abstract][Full Text] [Related]
59. [Prospective follow-up of 27 tumors of the oropharynx].
Pomar Blanco P; Gil-Carcedo García LM; Vallejo Valdezate LA
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):105-12. PubMed ID: 10804111
[TBL] [Abstract][Full Text] [Related]
60. [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.
Ishihara T; Kitajima K; Suenaga Y; Ejima Y; Komatsu H; Otsuki N; Nibu KI; Kiyota N; Takahashi S; Sasaki R
Nagoya J Med Sci; 2017 Feb; 79(1):27-36. PubMed ID: 28303058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
